David O’Reilly was appointed to the management board of BAT as group scientific and R&D director in January 2012. He graduated from Imperial College London in 1991 with a Ph.D. in molecular virology. He continued to pursue this area of research when he joined Advanced Technologies Cambridge, a subsidiary of BAT. In recent years at BAT, O’Reilly has been a driving force behind the creation and growth of BAT’s multidisciplinary global R&D effort in consumer-led, science-based innovation in next-generation tobacco and nicotine products. He has also led the company’s programs in corporate social responsibility, tobacco harm reduction and scientific and public health policy and engagement. He is the co-founder of the Global Tobacco & Nicotine Forum (GTNF) and a member of the GTNF advisory board.
